Çàðåãèñòðèðîâàòüñÿ

Ïîõîæèå òåìû

  1. ñõåìà ëå÷åíèÿ õëàìèäèîçà.
    îò qwert â ðàçäåëå Âåíåðîëîã-äåðìàòîëîã
    Îòâåòîâ: 40
    : 25.02.2023, 14:49
  2. Ñõåìà ëå÷åíèÿ õëàìèäèîçà !? È êòî îáÿçàí ëå÷èòü??
    îò Black Cloack â ðàçäåëå Âåíåðîëîã-äåðìàòîëîã
    Îòâåòîâ: 193
    : 08.12.2022, 12:12
  3. Íàçíà÷åíà ñõåìà ëå÷åíèÿ õëàìèäèîçà: 1. Ãîíîâàêöèíà 0, 1- 0, 2- 0, 3- 0, 4...
    îò Äìèòðèé 34 ãîäà â ðàçäåëå Óðîëîã-àíäðîëîã
    Îòâåòîâ: 1
    : 31.07.2004, 03:43
  4. Îòâåòîâ: 1
    : 24.07.2004, 08:42
  5. Îòâåòîâ: 1
    : 01.07.2004, 06:36
  1. ïîêåìîí
    #106
    ×èòàòåëü Íåäóã.Ðó
    ó ìåíÿ âîïðîñ.

    åñëè èìååò ìåñòî ïîðàæàíèÿ ãëîòêè è ñëèçñòîé ãëàçà õëàìèäèîçîì

    íóæíî ëè êàê òî ëîêàëüíî ëå÷èòü, èëè äîñòàòî÷íî îáû÷íîé ñõåìû ?

    ïîòîìó êàê ìîé èíôåêöèîíèñò íè÷åãî ïðî ãëàçà è ãëîòêó ñêàçàòü íå ñìîã

    îòïðàâèë ê ËÎÐó è îôòàëüìîëîãó à îíè â ñâîþ î÷åðåäü ìåíÿ íàïðàâèëè îïÿòü ê èíôåêöèîíèñòó.

  2. Èñêîðêà
    #107
    ×èòàòåëü Íåäóã.Ðó
    Èíòåðåñíî ìíåíèå óðîëîãîâ ïî ïîâîäó ëå÷åíèÿ õëàìèäèîçà . Âðîäå áû â ñòàíäàðòàõ ëå÷åíèÿ õëàìèäèîçà íå âèäíî íè÷åãî, êðîìå ìàêðîëèäîâ, äîêñèöèêëèíà è ôòîðõèíîëîíîâ - è íè÷åãî áîëåå. Èëè ÿ ñëûøó çâîí, íî íå çíàþ ãäå îí? .





    Òðè ãîäà íàçàä íà ôîðóìå áûëà äëèòåëüíàÿ äèñêóññèÿ ñ ä-ðîì Æèâîâûì.

    Ïðåäñòàâëåíèå î êîòîðîé, ìîæíî ïîëó÷èòü õîòÿ áû èç íèæå ïðèâåäåííûõ ïîñòîâ.

    http://forums./showpost.php?p=19346&postcount=30

    http://forums./showpost.php?p=19412&postcount=45

    http://forums./showpost.php?p=19417&postcount=46

    http://forums./showpost.php?p=19440&postcount=62

    http://forums./showpost.php?p=19443&postcount=63

    http://forums./showpost.php?p=19445&postcount=64



    Ïðîøëî âðåìÿ, è èç ðàçíûõ ñòðàí ìèðà ñòàëî âñå áîëüøå è áîëüøå ïîÿâëÿåòñÿ ñîîáùåíèé, ïîñâÿùåííûõ ïåðñèñòèðóþùåé õëàìèäèéíîé èíôåêöèè.



    http://www.medac.de/medac_international/txt_files/d_indications/102863791210085.htm

    Persistence

    Not recognized or recognized but not sufficiently treated C. trachomatis infections may convert into a persistent state. At this state the intracellular life cycle is characterized by the development of atypical, metabolically inert and thus antibiotic resistant inclusions. This biologic behaviour correlates with the clinical course after acute symptomatic disease, namely persistence or recurrence of symptoms which are not treatable with antibiotics. At the persistent state C. trachomatis downregulates the major outer membrane protein (MOMP) expression, still expresses continuously lipopolysaccharide (LPS) and overexpresses heat shock protein 60 (HSP60). HSP60 is a highly immunogenic protein that has been implicated in the pathogenesis of chronic inflammatory chlamydial diseases.



    http://arthritis-research.com/content/4/1/5

    However, antibiotic treatment of persistent organisms in the synovium has proved to be disappointing;



    http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=375316

    Without additional support from the host immune system, both persistent and static bacteria remain viable and may resume normal growth in changed conditions. Unlike most bacteria, the intracellular niche of persistent chlamydiae partially protects them from the immune system and thus can lead to complete failure of therapy. We have shown in this in vitro study that subinhibitory concentrations of antibiotics can induce persistence.



    http://www.jibtherapies.com/content/2/1/4

    These results argue that there is an important host-parasite relationship between chlamydial genital strains and the human host that determines organotropism of infection and the pathophysiology of disease. It was speculate that this relationship involves the production of indole by components of the vaginal microbial flora, allowing Chlamydiae to escape IFN-gamma-mediated eradication and thus establish persistent infection.



    Ïðè÷åì ïðîÿâëÿåòñÿ îáåñïîêîåííîñòü ïî âñå óñêîðÿþùåìóñÿ ðîñòó òàêèõ ôîðì âíóòðèêëåòî÷íîãî ïàðàçèòà. Ìîæåò êàê ðàç ñòàíäàðòû, êîòîðûå óïîìèíàåò óâ. Dr., îäíà èç ãëàâíûõ ïðè÷èí òàêîãî ðîñòà?

  3. Sunspot
    #108
    ×èòàòåëü Íåäóã.Ðó
    Uvazhaemy Vladimir Àðáóçlevich,

    Standarty lechenia boleznei vsego lish ktrazhenie luchih iz izvestnykh metodov ih lecheniya. Esli standartov net ili ih ne znayut, te zhe hlamidii nachinayt lechit kerosinom ili ozonom. Neadekvatnya terapia porozhdaet v tom chisle i rezistentnost. Kstati zaregistrirovannyh sluchaev antibitikorezistentnosti hlamidi po preznemu ne mnogo i neoslozhnennye hlamidiozy uspeshno lechatsya za 1 den bolee chem v 80% sluchaev bez vsakogo ozona/vo!benzina/vo!kerosina.



    Vashu ocherednuyu provokatsiyu razreshite rascenit kak popytku kosvennoi reklamy ozonoterapii dlya lecheniya infektsii. Poskolku effectivnos OT v lechenii lubogo zabolevahiya nikem oficialno ne priznana - vy opyat pytaetes navredit lyudam, zanimayas fakticheskim moshennichestvom. Esli rossiskomu zakonodatelstvu eto vse ravno, to mne net. Esche odna takaya provokatsia - s moderiruemogo mnoi foruma budu udalyat vashi ozonovye bredni bez preduprezhdeniy.



    Izvinyaus za latinitsu, pishu iz Germanii.

  4. àíòîíèî1
    #109
    ×èòàòåëü Íåäóã.Ðó
    Dear Vladimir Àðáóçlevich? What is the meaning of "usrednennye issledovaniya"? And how can we call the "trials" you are usually refer on - "ahineynie" or may be you have a special name for all those garbage you usually use as an arguments? To support immune systems? Well, no questions its a good idea! But the problem is what do you mean when you are going to "support" and/or "correct" it and what methodology are you going to employ? Ozone? Come on, Sir! Do you have reliable data showing that ozone make a real difference in treating chlamydia infection? The answer is certainly no! Please do not waste our time talking about nothing.

  5. NL
    #110
    ×èòàòåëü Íåäóã.Ðó
    YuriT, ÿ ìîãó ñîâåðøåííî ñ áîëüøîé äîëåé âåðîÿòíîñòè íàçâàòü åùå îäíó ïðè÷èíó, ïî÷åìó "ëå÷èëèñü èõ ìàìû äî è âî âðåìÿ áåðåìåííîñòè. Åñòü è òàêèå êòî ïðîëå÷åí èìåííî ïî ñòàíäàðòó ÂÎÇ íî äåòè òî çàáîëåëè", áîëåå òîãî, âû åå ñàìè îòìåòèëè.

    äî 70% ñóìàìåäà (äàæå â ìîñêâå!) ÿâëÿåòñÿ åñëè íå "ïîäêðàøåííûì êðàõìàëîì", òî íå ñîîòâåòñâóþùèì ïî äåéñòâèþ îðèãèíàëó. ïî òîé æå ïðè÷èíå îäíîêðàòíûé ïðèåì ñóìàìåäà íàçíà÷àåòñÿ â òå÷åíèè 7 (!) äíåé, ïðè÷åì äàæå áîëüøèíñòâî âðà÷åé ðåêîìåíäóþò ïîêóïàòü â ðàçíûõ àïòåêàõ.

    äàííûå âçÿòû èç íåîôèöèàëüíûõ, íî çàñëóæèâàþùèõ âíèìàíèÿ èñòî÷íèêîâ.

    äà ïîñìîòðèòå ñàìè, êàê ìîæíî îæèäàòü, ÷òî âî âñåõ "àïòå÷íûõ ïóíêòàõ" è ïðî÷èõ ëàðüêàõ áóäåò ïðîäàâàòüñÿ íå ïîääåëêà? âåäü îáëàäàòåëÿì ëàðüêà çàêðûòèå íå ñòðàøíî, îí åãî îòêðîåò ÷åðåç íåäåëþ ïîä äðóãèì íîìåðîì...

  6. stiker
    #111
    ×èòàòåëü Íåäóã.Ðó
    Ph.D. in biochemistry does not probably permit to feel the difference between suggested (proposed) and actual effect of treatment. Whatever happens with t-cells antibacterials works for chlamydia in the range up to 95%. What about ozone?



    P.S. How, Dear Vladimir Àðáóçlevich, about my remarks concerning ozone odor in German medicine? I've checked the second huge bookstore. Nothing about ozone! Secret weapon?

  7. Tito
    #112
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé Àëåêñåé Âèêòîðîâè÷!

    Ìîæåò Âàì ïîáåðå÷ü âðåìÿ â Ãåðìàíèè íà äîñòîïðèìå÷àòåëüíîñòè, à íå íà ïîèñê êíèæåê ïî îçîíó? Ïðè âñòðå÷å, åñëè îíè Âàñ òàê èíòåðåñóþò, îáÿçàòåëüíî ïîêàæó òðè íåìåöêèå ìîíîãðàôèè, ðóêîâîäñòâà ïî îçîíîòåðàïèè, ñ öâåòíûìè êàðòèíêàìè.

    Áîëåå òîãî, ñêàæó ïî ñåêðåòó, åñëè Âû çàéìåòåñü àíàëîãè÷íûì ïîèñêîì â Ðîññèéñêèõ êíèæíûõ ìàãàçèíàõ, òî òàê æå, âðÿä ëè áûñòðî íàòêíåòåñü íà ñîîòâåòñòâóþùóþ ëèòåðàòóðó. Íàâåðíîå è â Ðîññèè îçîíîòåðàïèÿ - ìèô, à ã-í Çàéöåâ – ïðèâèäåíèå.



    P.S. Èñ÷åçíîâåíèå êëèíè÷åñêèõ ïðîÿâëåíèé àêòèâíîãî õëàìèäèîçà íà 80% èëè äàæå 95% (êòî áîëüøå?). È äàæå íå îáíàðóæåíèå ýòèõ ïàðàçèòîâ ïðè ïîñåâå, îòíþäü åù¸ íå ãîâîðèò î ïîëíîé ýëèìèíàöèè õëàìèäèé èç îðãàíèçìà.

    È åù¸. Ïðîöåíò èçëå÷èâàíèÿ âñå âûøå è âûøå, ïî÷òè 100%, à çàáîëåâàåìîñòü õëàìèäèîçîì, â òîì æå ÑØÀ, âñå ðàñòåò è ðàñòåò. È êàê íàøè ïðåäêè áåç äîêñèöèêëèíà èëè àçèòðîìèöèíà, çà ïðîøåäøèå òûñÿ÷åëåòèÿ, óìóäðèëèñü âñå ïîãîëîâíî «íå îáðàñòè» âñåâîçìîæíûìè õëàìèäèÿìè? Èììóíèòåò, åñòåñòâåííî, â ðàñ÷åò íå áåðåì, îí âåäü íå äîêàçàí

  8. sergeitch
    #113
    ×èòàòåëü Íåäóã.Ðó
    The problem, Vladimir Àðáóçlevich, is that doctors in Germany have absolutely the same perception about ozone therapy like in any civilized country, no difference. You were trying to to argue that ozone in Gremany is used almost anywhere in ofiicial medicine, including emergency and University hospitals facilities. This is false! And absence on widely spread textbooks on ozone just illustrates that nobody seriously interested in this issue.



    You and Mr. Dvoryanchikov and all other quackers in the world are using the same ideology. If we follow your ideology we can state that if the person have no evidence of cancer, he/she should be given a "prophylactic tratment" for cancer anyway just to "improve the immune systems". No mater what kind of "treatments" are proposed by another medical gangster.



    I've never said that the immune system does not exist. I'm just doubting that any "immune correction/stimulation" can realy help in improving the current results of antibacterial therapy for chlamydiae.

  9. moymujnumizmat
    #114
    ×èòàòåëü Íåäóã.Ðó
    Óâàæàåìûé Àëåêñåé Âèêòîðîâè÷!

    ×òî æ Âû âñå ðàçãîâîð â ýòîé äèñêóññèè ïåðåâîäèòå íà îçîíîòåðàïèþ?

    ß âåäü ÇÄÅÑÜ, íåñìîòðÿ íà âñå Âàøè äîãàäêè, íå î íåé.

    Êðîìå òîãî, åñëè ÿ Âàì äàì àäðåñà óíèâåðñèòåòñêèõ öåíòðîâ â Ãåðìàíèè, ãäå ÎÒ çàíèìàþòñÿ, Âû ÷òî ïîåäåòå? Âû âåäü è Ìîñêâå êàòåãîðè÷åñêè îòêàçàëèñü ïðîåõàòüñÿ íà âïîëíå êîìôîðòàáåëüíîì àâòîìîáèëå òóäà è îáðàòíî.

    Èëè íà ìîè âîïðîñû â ïîñòñêðèïòóì ïðåäûäóùåãî ñîîáùåíèÿ ìîæíî îòâå÷àòü òîëüêî íàïàäàÿ íà îçîí? Îí âèíîâíèê?



    À ê ïðåäûäóùåìó ìîåìó ñîîáùåíèþ ìîæíî äîáàâèòü, ÷òî íåóêëîííûé ðîñò â ìèðå âòîðè÷íîãî èììóíîäåôèöèòà, ÷åìó ïðè÷àñòíî è ïîâñåìåñòíîå èñïîëüçîâàíèå ëåêàðñòâ (íàäî è íå íàäî), â òîì ÷èñëå àíòèáèîòèêîâ, ïðîáëåìà íè òîëüêî äëÿ õëàìèäèîçà.

    Èìåííî ïîýòîìó, íåñìîòðÿ íà ïîÿâëåíèå âñå áîëåå ýôôåêòèâíûõ ïðåïàðàòîâ, íàáëþäàåòñÿ óâåëè÷åíèå õðîíèçàöèè ìíîãèõ çàáîëåâàíèé. Áîëåå òîãî, ïîÿâëÿþòñÿ íîâûå çàáîëåâàíèÿ, âûçûâàåìûå ìèêðîîðãàíèçìàìè, êîòîðûå ðàíåå ñ÷èòàëèñü ìàëî ïàòîãåííûìè. Ê ïðèìåðó, http://www.apteka-expo.ru/apt2000/tezis/krptspor-ekpol.asp



    À âîîáùå-òî ëîçóíã: «çà÷åì íóæåí èììóíèòåò, êîãäà åñòü äîêàçàííûå àíòèáèîòèêè» - âïå÷àòëÿåò.

  10. abyss
    #115
    ×èòàòåëü Íåäóã.Ðó
    "íåóêëîííûé ðîñò â ìèðå âòîðè÷íîãî èììóíîäåôèöèòà" âïå÷àòëÿåò åùå áîëüøå.

    ß óæ ïèñàëà, ÷òî áûëà èñêðåíå óâåðåíà â íåäîñòóïíîñòè äëÿ íàøèõ ïåäèàòðîâ ïðîñòûõ àëãîðèòìîâ âåäåíèÿ îáû÷íûõ äåòåé,áåç ñòðàøèëîê ïðî èììóíîäåôèöèòû ïðè ñîïëÿõ, ïîêà âäðóã íå âûÿñíèëà, ÷òî ïåðåâåäåíî ðíåìàëî âïîëíå âìåíÿåìûõ êíèã íà ýòó òåìó..

    Âëàäèìèð ßêîâëåâè÷,êàê âûðàæàþòñÿ íàøè êîëëåãè ïî äðóãîìó ïîâîäó - ïðîáëåìà èììóíîäåôèöèòà âòîðè÷íîãî ÿâíî ãèïåðòðîôèðîâàíà â íàøåé ñòðàíå.

  11. Leshiy
    #116
    ×èòàòåëü Íåäóã.Ðó
    ïðîáëåìà èììóíîäåôèöèòà âòîðè÷íîãî ÿâíî ãèïåðòðîôèðîâàíà â íàøåé ñòðàíå.

    «Ïî äàííûì ÂÎÇ â íàñòîÿùåå âðåìÿ ïåðâîé îñîáåííîñòüþ ñîñòîÿíèÿ çäîðîâüÿ íàñåëåíèÿ â ìèðå ÿâëÿåòñÿ ñíèæåíèå èììóíîðåàêòèâíîñòè â öåëîì: ïî ðàçíûì èñòî÷íèêàì äî 50-70% ëþäåé èìåþò íàðóøåíèÿ èììóíèòåòà».



    Íî ýòî òàì, â «çàãíèâàþùåì» çàïàäå, â íàøåé ñòðàíå ïðîáëåì ñ èììóíèòåòîì íåòó. À åñëè âäðóã êîå-ãäå, ïîðîé è ïîÿâÿòñÿ, òî çàìåíèì àíòèáèîòèêàìè, äàæå ïðîòèâ ïîãàíûõ âèðóñîâ.

  12. Âèòàëèé.
    #117
    ×èòàòåëü Íåäóã.Ðó
    «Ïî äàííûì ÂÎÇ â íàñòîÿùåå âðåìÿ ïåðâîé îñîáåííîñòüþ ñîñòîÿíèÿ çäîðîâüÿ íàñåëåíèÿ â ìèðå ÿâëÿåòñÿ ñíèæåíèå èììóíîðåàêòèâíîñòè â öåëîì: ïî ðàçíûì èñòî÷íèêàì äî 50-70% ëþäåé èìåþò íàðóøåíèÿ èììóíèòåòà».





    ß òàê ïîíèìàþ, ÷òî ýòî ïðî ðàçâèâàþùèåñÿ ñòðàíû, òàì ãäå íåäîåäàþò è áîëåþò òðîïè÷åñêèìè áîëåçíÿìè. Íàñåëåíèÿ òàì ìíîãî

  13. merle
    #118
    ×èòàòåëü Íåäóã.Ðó
    ß òàê ïîíèìàþ, ÷òî ýòî ïðî ðàçâèâàþùèåñÿ ñòðàíû, òàì ãäå íåäîåäàþò è áîëåþò òðîïè÷åñêèìè áîëåçíÿìè. Íàñåëåíèÿ òàì ìíîãî



    Íó, åñëè ÑØÀ è Åâðîïåéñêèå ñòðàíû, ãäå òàê æå îòìå÷àåòñÿ ðîñò ðÿäà çàáîëåâàíèé, âèðóñíîé è ãðèáêîâîé ýòèîëîãèè – ðàçâèâàþùèåñÿ, òî Âû ïðàâû.

  14. els
    #119
    ×èòàòåëü Íåäóã.Ðó
    Â.ß., ïî÷¸ì öèòàòêà? Ãäå âçÿëè òî? Íåóæòî ÂÎÇ? À ÿ äóìàë, ÷òî âñå áîëåçíè îò ïîãîäû è îò ïðîäóëî? Îêàçûâàåòñÿ èììóíèòåò? À êàê æå íåðâíàÿ ñèñòåìà? Íàäî æå, 70%... ýòî òóò ñðåäè íàñ çíà÷èò... íó, ó ìåíÿ òî÷íî íåò! Â.ß., à ó Âàñ?





    «Ïî äàííûì ÂÎÇ â íàñòîÿùåå âðåìÿ ïåðâîé îñîáåííîñòüþ ñîñòîÿíèÿ çäîðîâüÿ íàñåëåíèÿ â ìèðå ÿâëÿåòñÿ ñíèæåíèå èììóíîðåàêòèâíîñòè â öåëîì: ïî ðàçíûì èñòî÷íèêàì äî 50-70% ëþäåé èìåþò íàðóøåíèÿ èììóíèòåòà».

  15. nikat
    #120
    ×èòàòåëü Íåäóã.Ðó
    Êîëëåãè, ýòà òåìà óæå îáñóæäàëàñü íåîäíîêðàòíî íà ôîðóìå è íå òîëüêî â îòíîøåíèè õëàìèäèé. Îïÿòü ó ìíîãèõ íàøèõ êîëëåã âîçíèêàåò æåëàíèå èçîáðåñòè âåëîñèïåä, óêðåïèòü ñâîè ïðîôåññèîíàëüíûå ïîçèöèè çàïóäðèâàíèåì ìîçãîâ íàóêîïîäîáíûìè ðàññóæäåíèÿìè î ñâîéñòâàõ ðàçëè÷íûõ çâåíüåâ èììóíèòåòà è ìåòîäèêàõ åãî (èììóíèòåòà) ñòèìóëÿöèè.  òàêèõ ñëó÷àÿõ ìíå âñïîìèíàåòñÿ ïðåïàðàò "Àðìåíèêóì", êîòîðûé òàêæå ïðåäñòàâëÿåò ñîáîé "ñòèìóëÿòîð èììóíèòåòà" è ïðåäëàãàëñÿ äëÿ ëå÷åíèÿ ÂÈ× èíôåêöèè. Ïîñëå âûñòóïëåíèÿ íà êîíôåðåíöèè ïî ÂÈ× â Àðìåíèè ìíå è îäíîìó èç ìîèõ êîëëåã àìåðèêàíñêîìó äîêòîðó ïðèøëîñü â ñðî÷íîì ïîðÿäêå óëåòàòü â Àìñòåðäàì, òàê êàê ïðîèçâîäèòåëè è ðàññïðîñòðàíèòåëè "Àðìåíèêóìà" áîëüøå íå ìîãëè "ãàðàíòèðîâàòü íàøó áåçîïàñíîñòü". Êàê âèäèòå êðèìèíàë òîæå ÷àñòî ñðàñòàåòñÿ ñ òàêîãî ðîäà ìÿãêî ãîâîðÿ àëüòåðíàòèâíûìè ìåòîäàìè âûêà÷èâàíèÿ äåíåã. Õëàìèäèè êîðìÿò óæå íåñêîëüêî ïîêîëåíèé ðîññèéñêèõ óðîëîãîâ (ïóñòü äîêòîð Æèâîâ ìåíÿ ïðîñòèò çà óïîìèíàíèÿ íàçâàíèÿ åãî ñïåöèàëüíîñòè â ïðèëîæåíèè ê ýòèì øàáàøíèêàì) è îíè òàê ïðîñòî íå ñäàäóò ñâîè ïîçèöèè. Ìåäèöèíñêîé àññîöèàöèè êàê òàêîâîé íåò, ïîýòîìó áåç âìåøàòåëüñòâà ãîñóäàðñòâà (â ëèöå íàâåðíîå Ìèíçäðàâà) õëàìèäèéíûé áåñïðåäåë áóäåò ïðîäîëæàòüñÿ. Ïðèâåñòè âñå ýòî ê îáùåìó çíàìåíàòåëþ ìîæíî òîëüêî íà÷èíàÿ ñ ñåðòèôèêàöèè ëàáîðàòîðèé (ó íàñ âñå êîìó íå ëåíü äåëàþò ÄÍÊ ïðîáû), ôèíàíñèðîâàíèÿ íîðìàëüíûõ ðåôåðåíòíûõ áàêòåðèîëîãè÷åñêèõ ëàáîðàòîðèé. Òîëüêî â îäíîé Ìîñêâå åñòü íåñêîëüêî äåñÿòêîâ ïðîèçâîäèòåëåé ïðàéìåðîâ äëÿ äèàãíîñòèêè ÇÏÏÏ, òîãäà êàê â Àìåðèêå òîëüêî 2 èëè 3 êîìïàíèè äåëàþò ïðàéìåðû (íà ïðàêòèêå ïðèõîäèëîñü âñòðå÷àòüñÿ òîëüêî ñ Abbott). Íåïðàâèëüíàÿ (íèçêîñïåöèôè÷íàÿ) äèàãíîñòèêà ÿâëÿåòñÿ îäíîé èç ïðè÷èí "íåèçëå÷èìîñòè õëàìèäèé".  ïðèëîæåíèè ê çàäàííîìó âîïðîñó ÿ ñêîðåå âñåãî ðåêîìåíäîâàë áû ëå÷åíèå äîêñèöèêëèíîì. Õîòåëîñü áû óçíàòü ñ ÷åì ñâÿçàíà ðåêîìåíäàöèÿ îòíîñèòåëüíî êîíêðåòíîãî áðåíäà (Þíèäîêñ). Äîêñèöèêëèí - ïðåïàðàò, êîòîðûé èìååò ìàññó ãåíåðèêîâ (ïðåïàðàòó óæå ñòî ëåò).

Êëèíèêà ñòîìàòîëîãèè è êîñìåòîëîãèè â Ìîñêâå

Ìåòêè ýòîé òåìû

Âàøè ïðàâà

  • Âû ìîæåòå ñîçäàâàòü íîâûå òåìû
  • Âû ìîæåòå îòâå÷àòü â òåìàõ
  • Âû íå ìîæåòå ïðèêðåïëÿòü âëîæåíèÿ
  • Âû íå ìîæåòå ðåäàêòèðîâàòü ñâîè ñîîáùåíèÿ
  •